Work

Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors

Year: 2026

Type: article

Study design: Observational Study

Source: Journal of Thrombosis and Haemostasis

DOI: 10.1016/j.jtha.2026.05.028

Authors: Thomas F. Fusillo, Avi Leader, Simon Mantha, Helen Ajufo, Andriy Derkach, Adam Schoenfeld, Rohan Singh, Peter Kaplinsky, Jeffrey I. Zwicker

Institutions: Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine, Washington University in St. Louis

Language: English

Topic: Venous Thromboembolism Diagnosis and Management

Subfield: Internal Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, National Institutes of Health, National Cancer Institute

Awards: G3340923374, Cancer Center Support Grant

OpenAlex ID: W7163636174

FWCI:

Cites:

Cited by:

Related to: 10